Progressive Rash and Arthralgias in a Teenage Male

News
Poll

PT Video: A short course of steroids was ineffective. He returns to ED c/o worsening joint and abdominal pain. Can you Dx?

A 16 y/o male presents with 9 days palpable, purpuric, non-pruritic rash that began on legs and spread quickly upwards; also c/o polyarticular arthritis, abdominal pain. Mild improvement after short course of steroids, finished 2 days ago. Joint/abdominal pain now worse. PMH, noncontributory; no sick contacts. What else do you need to know?

 

What is your initial impression?

A. Henoch-Schönlein purpura
B. Epstein-Barr virus infection
C. Juvenile idiopathic arthritis (Still’s disease)
D. Systemic lupus erythromatosis (SLE)
E. Thrombocytopenic disease (ITP, TTP, DIC)
F. Rickettsial disease
G. Purpura fulminans

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Related Content
New Option for Chronic Hand Eczema Gets FDA Green Light: Daily Dose / image credit: ©New Africa/AdobeStock

New Option for Chronic Hand Eczema Gets FDA Green Light: Daily Dose

Sydney Jennings
August 2nd 2025
Article

Your daily dose of the clinical news you may have missed.

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Sydney Jennings
August 2nd 2025
Podcast

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings / image credit Courtesy of Bispebjerg Hospital

Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings

Grace Halsey
August 2nd 2025
Article

Atopic dermatitis flares should be factored in to an assessment of disease severity and prognosis, the authors note, and a threshold established for acceptable frequency.

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Sydney Jennings
August 2nd 2025
Podcast

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose / image credit: ©New Africa/AdobeStock

Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose

Sydney Jennings
August 2nd 2025
Article

Your daily dose of the clinical news you may have missed.

Lebrikizumab Found Safe, Effective in Patients With Skin of Color With AD: Daily Dose / image credit: ©New Africa/AdobeStock

Lebrikizumab Found Safe, Effective in Patients With Skin of Color With AD: Daily Dose

Sydney Jennings
August 2nd 2025
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.